AUG 14, 2026 · PHASE 1 TRIAL
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
ClinicalTrials.gov
Phase 1b registry record with recruitment completed but no results posted; describes planned efficacy and safety exploration in a small, dose-ranging study of a novel agent.
Reported
Planned sample size90
Planned enrolled subjects (brief…30
Pretreated randomized to furmoner…10